2017 M&A review - pharmaceuticals & medical devices sector

Apr 2018

China pharmaceutical sector M&A fell by 17% in 2017 to US$17.12 billion, but China mainland outbound activity increased by 10% and 97% in number of deals and in deal value. Meanwhile, China medical device M&A fell by 36% in 2017 to US$4.94 billion, the lowest amount in the past three years.


 Download 2017 M&A review

China pharmaceuticals sector China medical devices sector

Contact us

Xun Tang

China Central Transaction Services Leader, PwC Hong Kong

Tel: +[86] (21) 2323 3396

Follow us